Adynxx Inc ADYX
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.04
- 52-Week Range
- $0.00–0.04
- Bid/Ask
- $0.00 / $0.60
- Shares Outstanding
- 5.81M
- Market Cap
- $580.79
- Volume/Avg
- 881 / 734
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 6
- Website
- http://www.adynxx.com
Valuation
|
Metric
|
ADYX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ADYX
|
|---|---|
Quick Ratio | 0.02 |
Current Ratio | 0.18 |
Interest Coverage | −2.61 |
Quick Ratio
ADYX
Profitability
|
Metric
|
ADYX
|
|---|---|
Return on Assets (Normalized) | −129.94% |
Return on Equity (Normalized) | −1,026.61% |
Return on Invested Capital (Normalized) | −148.29% |
Return on Assets
ADYX
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|S@sgY@D | LOCK|$%N@ | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|KwwVtcD | LOCK|@!l<W | $83B | |||
| Moderna Inc
MRNA
| LOCK|#xd!l&? | LOCK|%^& | $80B | |||
| argenx SE ADR
ARGX
| LOCK|h!MX&B | LOCK|XS^ | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|w?yH^fd | LOCK|f< | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|?Q?%^%T | LOCK|qF<@J | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|tf&&<Gl | LOCK|vd@<c | $28B | |||
| Incyte Corp
INCY
| LOCK|MXkyYQ | LOCK|K! | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|CK#>#lP | LOCK|nqJ | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|qxChRn | LOCK|@HW | $14B |
United States